Development and Validation of Analytical HPLC Method for Identification and Assay of Enoxaparin Sodium in Injectable Preparations

Development and Validation of Analytical HPLC Method for Identification and Assay of Enoxaparin Sodium in Injectable Preparations

Introduction. Enoxaparin sodium-containing drugs are included in relevant protocols for COVID-19 therapy. An increase in the production volume of such drugs leads to a demand for available and precise methods of identification and quantitative measurement of the active ingredient in the preparations...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Pshenichnov, K. V. Kondrasheva
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-02-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	enoxaparin sodium gel permeation hplc identification assay validation
Online Access:	https://www.pharmjournal.ru/jour/article/view/1438
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation study on the assay method for anti-factor IIa potency of enoxaparin sodium
by: Xiaorong Yang, et al.
Published: (2024-12-01)

DEVELOPMENT, VALIDATION AND APPLICATION OF ANTI-Xa- AND ANTI-IIa-ENOXAPARINE SODIUM ASSAY
by: B. Yu. Margaeva, et al.
Published: (2019-01-01)

Establishment and validation of a method for determining anti-Xa factor potency of enoxaparin sodium
by: En Zhang, et al.
Published: (2025-05-01)

Analytical method (HPLC), validation used for identification and assay of the pharmaceutical active ingredient, Tylosin tartrate for veterinary use and its finite product Tilodem 50, hydrosoluble powder
by: Maria Neagu
Published: (2010-12-01)

The validation of the analytical method (HPLC), use for identification and assay of the pharmaceutical active ingredient, colistine sulphate and the finished product Colidem 50 – hydrosoluble powder, in SC DELOS impex ‘96 SRL
by: Maria Neagu,, et al.
Published: (2011-06-01)

Is Enoxaparin Sodium Exactly Safe For Subcutaneous Fibroblast?: A Cell Culture Study
by: Mehmet Ali Onur, et al.
Published: (2021-04-01)

UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01)

Role of lncRNA NONMMUT104330.1-miR-709-DDX58 axis in mediating immunomodulatory effects of enoxaparin sodium bone cement on macrophage polarization and inflammatory response
by: Weiye Fan, et al.
Published: (2025-08-01)

Novel Green RP-HPLC Method for Simultaneous Determination of Sodium Diclofenac and Benzyl Alcohol as Bulk Mixtures and in Pharmaceutical Injectable Forms
by: Ola Mahmod Younes
Published: (2025-05-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Development and Validation of RP-HPLC Method for the Determination of Dexrabeprazole Sodium
by: Semra Yılmazer Keskin, et al.
Published: (2021-12-01)

Development of Green RP-HPLC method for determination of sorafenib in film-coated tablets
by: Sanija Zulfikjari, et al.
Published: (2024-12-01)

Comparing Cesarean Incisional Complications in Women With and Without Enoxaparin: A Quasi‐Experimental Study
by: Leili Hafizi, et al.
Published: (2025-02-01)

Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?
by: I. S. Yavelov
Published: (2011-12-01)

Changes in coagulation parameters in polytrauma patients with different body mass index according to the enoxaparin-sodium dosing strategy under conventional versus restrictive fluid therapy regimens
by: М.О. Gogiya, et al.
Published: (2025-04-01)

EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS
by: A. M. ZUDIN, et al.
Published: (2017-12-01)

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study
by: Zahra Sahraei, et al.
Published: (2025-01-01)

Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
by: Xiaofeng Zheng, et al.
Published: (2025-05-01)

The safety of enoxaparine use in elderly with acute myocardial infarction
by: Despotović Nebojša, et al.
Published: (2007-01-01)

Analytical HPLC-separation of retinoid derivatives of natural and 3,4-didehydro series
by: N. E. Belikov, et al.
Published: (2014-02-01)

The effects of heparinized normal saline flushing and prophylactic enoxaparin on central venous catheter thrombosis in PICU hospitalized pediatric
by: Maryam Mohebbi, et al.
Published: (2024-07-01)

Enoxaparin-induced hepatotoxicity: clinical cases and literature review
by: Yu. N. Krovko, et al.
Published: (2021-03-01)

DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC
by: T. L. Batalova, et al.
Published: (2019-01-01)

Development and validation of an HPLC-DAD analytical method for quantitative and simultaneous determination of cefoperazone and prednisolone in intramammary ointment
by: Patrícia Espinosa dos Santos, et al.
Published: (2025-07-01)

Development and Validation of a Simple Analytical Method to Quantify Tocopherol Isoforms in Food Matrices by HPLC–UV–Vis
by: María Fernanda Arias-Santé, et al.
Published: (2024-09-01)

Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study
by: Salam Ibrahim Abou Safrah, et al.
Published: (2025-05-01)

Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system
by: Bo-wen Lu, et al.
Published: (2025-05-01)

Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification
by: Riuna O’Neill, et al.
Published: (2025-07-01)

SIMULTANEOUS DETERMINATION OF AMINOTRIAZOLE AND TRIAZOLOPYRIMIDINONE - SUBSTRATE AND INTERMEDIATE IN THE SYNTHESIS OF «TRIAZIDE» BY HPLC
by: A. V. Baklykov, et al.
Published: (2019-01-01)

VALIDATION OF ANALYTICAL METHOD OF ASSAY OF SERPISTEN IN OINTMENT
by: E. I. Molokhova, et al.
Published: (2019-01-01)

Analytical Method for the Simultaneous Determination of Albendazole and Metabolites Using HPLC-PDA: A Validation Study
by: E. Milena Vázquez, et al.
Published: (2025-05-01)

Diagnostic Assay Validation Network (DAVN) Progress and Evolution
by: Poonam Sharma, et al.
Published: (2025-06-01)

Identification and pharmacokinetics of saponins in Rhizoma Anemarrhenae after oral administration to rats by HPLC-Q-TOF/MS and HPLC-MS/MS
by: Wang Hai-Qiao, et al.
Published: (2021-12-01)

Development and Validation of a Novel Analytical Method (Ion Pair HPLC) For Separating and Determining Bisoprolol Fumarate and Carvedilol in Pure and Their Pharmaceutical Forms.
by: Duaa Alhuseen, et al.
Published: (2024-06-01)

Bridge-therapy with enoxaparin in the preoperative period of endarterectomy Terapia-ponte com enoxaparina no período pré-operatório da endarterectomia
by: Jair Leopoldo Raso, et al.
Published: (2010-10-01)

DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
by: Syed Hassan Murtaza, et al.
Published: (2024-03-01)

Recent HPLC-UV Approaches for Cannabinoid Analysis: From Extraction to Method Validation and Quantification Compliance
by: Eduarda M. P. Silva, et al.
Published: (2025-05-01)

Association of early enoxaparin prophylactic anticoagulation with ICU mortality in critically ill patients with chronic obstructive pulmonary disease: a machine learning-based retrospective cohort study
by: Shan Lin, et al.
Published: (2025-05-01)

Development of a Validated HPLC-UV Method for the Determination of Panthenol, Hesperidin, Rutin, and Allantoin in Pharmaceutical Gel-Permeability Study
by: Sofia Almpani, et al.
Published: (2025-01-01)

Validation of quantitative determination methods of diphenhyramine tablets by high performance liquid chromatography
by: S. L. Zagorodniy, et al.
Published: (2015-04-01)